publicFounded 2011
Caribou Biosciences
Funding Summary
Total Funding
$400M+
Latest Valuation
~$300M (public market cap, Apr 2026)
About
Co-founded by Jennifer Doudna, develops off-the-shelf CRISPR-edited cell therapies using proprietary chRDNA hybrid system for hematological cancers.
platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →